{"ticker": {"uuid": "43595c3a-7ecc-4098-9d09-daabc1fa8326", "symbol": "4519", "name": "Chugai Pharmaceutical Co., Ltd.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Chugai Pharmaceutical Co Ltd (4519)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOVjAxZGJZdnJBNlZWaGdRTXIweFljdVdwRkhEaGxwcm9sTkEwZlpqeWhXQU43d2xLOEtkTWtfUnpLeWk5Q0lmOE1vUERRZllwS3dLa3pvWEo4eUUxM2l1ajBwazRVQi0xTkhMWERFZm9USWdyUUt4ZEJjdFd4S0QzaVNVZmhNUU01?oc=5", "source_name": "MSN", "published_at": "2026-07-14T09:37:37+00:00", "published_display": "14 Jul 2026 09:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Chugai Pharmaceutical Co., Ltd. Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5iVG5QLTVTemFvVnNicHJGdHo2bWh3ZEEyX3NWalMzMDFhSkxDalMwV1A2T09sYWZTWWd1ektQWHZfb19FR1Y3TTZCSGtZVFhQWjhtQWg1R0pHQTVGVXRURUl3?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T19:50:35+00:00", "published_display": "13 Jul 2026 19:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CHUGAI PHARMACEUTICAL CO., LTD. (4519)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNcU15Sjc4QnZfaVNRWXR3Vk9WcWpONncxUjktTmxKNjJtLWFCQVBrVGpPbGtxVGhhcHZEdHB3Q3ZKbFl4SnpFVzB3aENCaVg3V0V0NTlycWEyVldWSGY1NldkQWs5Ml90OTc5N3Zqc2RDOFRPdlBBZlFMM1B3cVM2Z2hJdk9iY2tDMkE?oc=5", "source_name": "MSN", "published_at": "2026-07-07T06:45:45+00:00", "published_display": "07 Jul 2026 06:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai Pharmaceutical Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:CHGCY) 2026-04-24", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPXy1QSkY1a05OSnhlOWdUNUdESVZWc0k5azM1S25VRUJocnNkX3FWOVVUS3Z6QTRFd1pTUmNCaFNVTHg0Zk9UTm4yRXdUV051a3dCUzJaQUtOdFhfWDdNUW5tZjdpZEstMlVkZXcwNUVNSHVpMW9UaTh3cjhBTl9lampWcDdrODhCVHk5ZmRqcDByRUZFZkNlcXFtbzluUHk0MWtmSFM4dFpKQ0diMGxKYUJ3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai Selected for the \u201cKENKO Investment for Health\u201d for the Third Consecutive Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPa2hjRmdvQjJDSmI3Uk9UYjVzX2huQkRrUUNOVWd2U2NBUjVwdk5jY3ZoTE5sd1pDbkVUVnJubWV1Q19aMkNtaWZkUE5NUUppWTBJUEFXa241anloTU91WjRCTmFxTi1qX2lia0ItQkdTVTc2VVF5THY1X1VUbDFKWA?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jan 29,2026 | Chugai Relocates Head Office | News | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQeXRSNkdVRm9UaFNUblF3RGZWR1NyeXpzTWNQUzR0MXA3Tm5nSlZTZE1yV1M4bWg5X1lrWjF5c3lHSER4cWo4RGRZQVJTNU1qUXlSNnVFOHAwV0dfX1MxUVEyczloNWFfR2Y5clc0Q3lXYTNUc1RSOXRiVTVVdzhROQ?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai Pharmaceutical Co., Ltd. (TSE:4519) stock most popular amongst public companies who own 61%, while individual investors hold 20%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPaVUzeHBWVGZ6Ynd2bXFpNkNCRm5JVWVHVzI5ZkN4QnhLQjlLR3Z5U3FETEVJSnl5SzJQMEtOV2JMbEhnVU5YbXhOOXVEVWc3WEF4WG54UmgtZWhTQ29vZV8zWjduSjRIdjVPam54VlZKc0tJUTlKdHVIUUItOTM2X1E5b0REZ2p5M3RaV24yeFlReVR1Snp3cXZ6QzJMbmtISlRrdXd3cnRTZnVmMExzbklnNXJFSzQ3cW1Vc3d2dlVpLUpfX2pSQWFkWXNyS0FhTWhpMGhoZlktcHhVWFk4NWZocW9YcUd5SHlyeUQ1TzLSAfYBQVVfeXFMT29aMW9SNmFQaW1oaFBwdmF1d1pOS2FPTXAyay1ORUxiYVdyU04yNGRGNkNpVklDUHpNX1pQSVF4Znd6M255WG9BZWtTTXdlVlV6Y2ExUlFhZ0x3Z2dvTGpOazVpNEVmSWttRmJCMER3NDVid0lkSkxmbUtDUTF4TDVWQTY1N2JuUnJZaVlLWWN4VDJGZDA2eUZsSVlHbWxsYVN1aGljdzZJQWEyc0M0VjJKaEhoZ3hHNUxfNE4xMllITEJvRmFiNEdGOGI5aG1VQUxNQXRaam9yZ3FLQWxNREpscDd6RThXT3ktcUhzWjJvNHpxS1JB?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai to enhance kidney disease portfolio with Renalys", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFBRRGlHVXFEaUhQWHNaUXVHNFFNNHQ3X0Z0enlHRS1QZWRseUVlWno2bl9DYXhFWVNYb3h3a2tmQnlMOTMxZ09lRlZhWm9DUzBkNUZsZGt0T0JxdFRYSVZXbG1qU0p4cjFlVVp2bEJ5WlJac200N2JWMA?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-10-27T07:00:00+00:00", "published_display": "27 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Renalys Pharma to be Acquired by Chugai Pharmaceutical", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOTGdHdldkakh1SDByZVZYMHlyZGdZMzVoa1h6LVpLSlZDN3ZNamppcE9kUXhFVWVsYV9Yak8xTkF0ZmNPRURrS1d3ZExUVVBYMXpEdU1kZ2JTakN2TnpTS0xUMGdxdEZtMTE2Ry1sWFo2Uy0wb0xDN3BQMjNQbVlTcko2OVhEMThNXzlpRlN2czBydGsxVFVFSQ?oc=5", "source_name": "citybiz", "published_at": "2025-10-24T07:00:00+00:00", "published_display": "24 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPZXJnVnZpRDZYOVExZExISWFBNUh1UFhOb3ZickdWVkl2Mk1STC1FcERrcmxXdlRZekROaEdLb1Jybzh3Sl9vRUNXdzJzaVRYZzVOZHhJVi1YU21VUkdwVXU3dk9kaEtkUmt0TU1GTV9EalZFUDdyOUhhZWdnNEdCMDdncVFndXdRNHVlYkQ3QURTM1MzRUNacHVueW9HTGNIVnBkSTlUSk5QT3FzV3o0OHp0RmJldkVHSFhHSHRGdm15Q2E2VnNseG9kYU54LTd6SkYxbk51WDIzbXo1LVFKYXBRcEZ1UQ?oc=5", "source_name": "Reuters", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQTVphdWxvOEtLa0JsUWc3NVNORXNyanJUeDgyYnVfbVBWX01LQzdZYnZ4ejlWY2NwejBIcllYYUFhelloYjJOYll4Vm00cnVSNXBYLTM2OVI1QXpyRUNkSDVkSnRja21JQmNsYkNhc0NLZ0pGQVRSbzFaZVN1NFJ1cEpXdVNPZw?oc=5", "source_name": "Market source", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai Sinks Most Since 1977 on Obesity Drug Disappointment", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNOVprMVR3dkp6SUs4UWpHU3BibVlDRWdITjFfNWZzSmFUV0t2VmhiTTBKRTdibm5xU2x1ZTNEUnhEXzhMNFh1VThENFhfaFI0TlZlaXJtQmNxZEhkVS14TWt2MmI2Q18wX1dITTMtNUcxZFdkeFhFY3hNeFUzWkV3ckF5VlBVMkx0MV9kY2M3ZnZzLU5rRjZyMllSMXVwYnFTcG5EUXFwNEJZcGZLWVE?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-08-07T07:00:00+00:00", "published_display": "07 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPejJUWU56RVZyQXVOVEk4ZEo3dUtKdC1qeUl1Qlo1a1hZNjVWbHEtQlVVeFRxSzhVazFTTmhBVnRUSVVkS2YzZzlHVHJ4UHV5VGZNSjV4U25tMUtBOUotMDNYTW5OSmhtRzdmVl83R1V5VnJmVUJQZ0hMTG1zSjY5bXFCNl9oekdxOUZXbkcwTGozUjg?oc=5", "source_name": "The Japan Times", "published_at": "2025-04-18T07:00:00+00:00", "published_display": "18 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Construction of Chugai\u2019s New Research Center \u201cChugai Life Science Park Yokohama\u201d Reached Completion", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1vaGV1cjdyZDZsV0NjVzNoOG9jbHlDaE9lT3o5Z1dOV1llNkVheWFiallFTTlwRDYzZ3FvRW44cEhtZEY3VWpNS2tJbWs3dV9wTU5PZl8yQUlfUHpMcDhZSjRUVTdWUnJkcXVES2NINHNRSEV3QjdGbHN4d2NWOWM?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2022-10-18T07:00:00+00:00", "published_display": "18 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Growth strategy \u201cTOP I 2030\u201d | Management Policy | Investor Relations | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQb2pEYTVaS3prb0VvNzZtcE1fZXFTUmJvWTZfWEdIb0pQN2VNakRzM3V0LVhIR1dibHZoclBraWhqeVdNLWxLd3Fna3M2dmVadVNXUDRBNHpKYXBQRDE3YUx1bnJPY0JEN0c2THl6aF9aRlpQeGFXYlJVTnlPa2RlcHFn?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2021-02-04T09:35:08+00:00", "published_display": "04 Feb 2021 09:35", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sustainability Data 2025 | Data | Sustainability | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFBjRWlRMU8yNFFuWUNrZkY3bHk0QVVKbHY5SDFQLTd0Mlo2UGJJVnFFaVFaOW1WQlN6bjlpRy1hNUFEUUdleDVDejgxd0VUbjJDRUlLSG5VempIczkzV3BxbTlXWVI3cm1wbXFuWHFPYnlBWlRfck9pX1Bn?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2019-10-01T02:34:37+00:00", "published_display": "01 Oct 2019 02:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strategic Alliance with Roche | Our Strategy | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxObklpOTNSdV8tQmlSQTJKdWVhcUZQLWxxOUpHMzg4b3RyQVNFTnByVE5KOG9PajRuNXZRSk5Ba3ZfVHhzOGJ1Y091RWljSHZuYkdSdUIxUmV4WnB5cmQ4NnBiSkVLalZhdjlBckxqQnU5SkY1OGNveTVEeFhyNmd3TQ?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2018-10-01T01:21:56+00:00", "published_display": "01 Oct 2018 01:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investor Relations | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTFBYRXBqcTQ4RXJQZFU5ZkRDWVR1ZVRyMloxUWxIRGtPQlI3V2EzWFhjdUl1Q2lwVDhsa0JUQVRBeG92YUhLYzBmd0J3SXhqd3dqOXM4ZQ?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2006-06-11T04:29:33+00:00", "published_display": "11 Jun 2006 04:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Chugai Pharmaceutical Co Ltd (4519)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOVjAxZGJZdnJBNlZWaGdRTXIweFljdVdwRkhEaGxwcm9sTkEwZlpqeWhXQU43d2xLOEtkTWtfUnpLeWk5Q0lmOE1vUERRZllwS3dLa3pvWEo4eUUxM2l1ajBwazRVQi0xTkhMWERFZm9USWdyUUt4ZEJjdFd4S0QzaVNVZmhNUU01?oc=5", "source_name": "MSN", "published_at": "2026-07-14T09:37:37+00:00", "published_display": "14 Jul 2026 09:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Chugai Pharmaceutical Co., Ltd. Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5iVG5QLTVTemFvVnNicHJGdHo2bWh3ZEEyX3NWalMzMDFhSkxDalMwV1A2T09sYWZTWWd1ektQWHZfb19FR1Y3TTZCSGtZVFhQWjhtQWg1R0pHQTVGVXRURUl3?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T19:50:35+00:00", "published_display": "13 Jul 2026 19:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CHUGAI PHARMACEUTICAL CO., LTD. (4519)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNcU15Sjc4QnZfaVNRWXR3Vk9WcWpONncxUjktTmxKNjJtLWFCQVBrVGpPbGtxVGhhcHZEdHB3Q3ZKbFl4SnpFVzB3aENCaVg3V0V0NTlycWEyVldWSGY1NldkQWs5Ml90OTc5N3Zqc2RDOFRPdlBBZlFMM1B3cVM2Z2hJdk9iY2tDMkE?oc=5", "source_name": "MSN", "published_at": "2026-07-07T06:45:45+00:00", "published_display": "07 Jul 2026 06:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai Pharmaceutical Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:CHGCY) 2026-04-24", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPXy1QSkY1a05OSnhlOWdUNUdESVZWc0k5azM1S25VRUJocnNkX3FWOVVUS3Z6QTRFd1pTUmNCaFNVTHg0Zk9UTm4yRXdUV051a3dCUzJaQUtOdFhfWDdNUW5tZjdpZEstMlVkZXcwNUVNSHVpMW9UaTh3cjhBTl9lampWcDdrODhCVHk5ZmRqcDByRUZFZkNlcXFtbzluUHk0MWtmSFM4dFpKQ0diMGxKYUJ3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai Selected for the \u201cKENKO Investment for Health\u201d for the Third Consecutive Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPa2hjRmdvQjJDSmI3Uk9UYjVzX2huQkRrUUNOVWd2U2NBUjVwdk5jY3ZoTE5sd1pDbkVUVnJubWV1Q19aMkNtaWZkUE5NUUppWTBJUEFXa241anloTU91WjRCTmFxTi1qX2lia0ItQkdTVTc2VVF5THY1X1VUbDFKWA?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jan 29,2026 | Chugai Relocates Head Office | News | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQeXRSNkdVRm9UaFNUblF3RGZWR1NyeXpzTWNQUzR0MXA3Tm5nSlZTZE1yV1M4bWg5X1lrWjF5c3lHSER4cWo4RGRZQVJTNU1qUXlSNnVFOHAwV0dfX1MxUVEyczloNWFfR2Y5clc0Q3lXYTNUc1RSOXRiVTVVdzhROQ?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai Pharmaceutical Co., Ltd. (TSE:4519) stock most popular amongst public companies who own 61%, while individual investors hold 20%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai to enhance kidney disease portfolio with Renalys", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFBRRGlHVXFEaUhQWHNaUXVHNFFNNHQ3X0Z0enlHRS1QZWRseUVlWno2bl9DYXhFWVNYb3h3a2tmQnlMOTMxZ09lRlZhWm9DUzBkNUZsZGt0T0JxdFRYSVZXbG1qU0p4cjFlVVp2bEJ5WlJac200N2JWMA?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-10-27T07:00:00+00:00", "published_display": "27 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Renalys Pharma to be Acquired by Chugai Pharmaceutical", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOTGdHdldkakh1SDByZVZYMHlyZGdZMzVoa1h6LVpLSlZDN3ZNamppcE9kUXhFVWVsYV9Yak8xTkF0ZmNPRURrS1d3ZExUVVBYMXpEdU1kZ2JTakN2TnpTS0xUMGdxdEZtMTE2Ry1sWFo2Uy0wb0xDN3BQMjNQbVlTcko2OVhEMThNXzlpRlN2czBydGsxVFVFSQ?oc=5", "source_name": "citybiz", "published_at": "2025-10-24T07:00:00+00:00", "published_display": "24 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPZXJnVnZpRDZYOVExZExISWFBNUh1UFhOb3ZickdWVkl2Mk1STC1FcERrcmxXdlRZekROaEdLb1Jybzh3Sl9vRUNXdzJzaVRYZzVOZHhJVi1YU21VUkdwVXU3dk9kaEtkUmt0TU1GTV9EalZFUDdyOUhhZWdnNEdCMDdncVFndXdRNHVlYkQ3QURTM1MzRUNacHVueW9HTGNIVnBkSTlUSk5QT3FzV3o0OHp0RmJldkVHSFhHSHRGdm15Q2E2VnNseG9kYU54LTd6SkYxbk51WDIzbXo1LVFKYXBRcEZ1UQ?oc=5", "source_name": "Reuters", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQTVphdWxvOEtLa0JsUWc3NVNORXNyanJUeDgyYnVfbVBWX01LQzdZYnZ4ejlWY2NwejBIcllYYUFhelloYjJOYll4Vm00cnVSNXBYLTM2OVI1QXpyRUNkSDVkSnRja21JQmNsYkNhc0NLZ0pGQVRSbzFaZVN1NFJ1cEpXdVNPZw?oc=5", "source_name": "Market source", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chugai Sinks Most Since 1977 on Obesity Drug Disappointment", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNOVprMVR3dkp6SUs4UWpHU3BibVlDRWdITjFfNWZzSmFUV0t2VmhiTTBKRTdibm5xU2x1ZTNEUnhEXzhMNFh1VThENFhfaFI0TlZlaXJtQmNxZEhkVS14TWt2MmI2Q18wX1dITTMtNUcxZFdkeFhFY3hNeFUzWkV3ckF5VlBVMkx0MV9kY2M3ZnZzLU5rRjZyMllSMXVwYnFTcG5EUXFwNEJZcGZLWVE?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-08-07T07:00:00+00:00", "published_display": "07 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPejJUWU56RVZyQXVOVEk4ZEo3dUtKdC1qeUl1Qlo1a1hZNjVWbHEtQlVVeFRxSzhVazFTTmhBVnRUSVVkS2YzZzlHVHJ4UHV5VGZNSjV4U25tMUtBOUotMDNYTW5OSmhtRzdmVl83R1V5VnJmVUJQZ0hMTG1zSjY5bXFCNl9oekdxOUZXbkcwTGozUjg?oc=5", "source_name": "The Japan Times", "published_at": "2025-04-18T07:00:00+00:00", "published_display": "18 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Construction of Chugai\u2019s New Research Center \u201cChugai Life Science Park Yokohama\u201d Reached Completion", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1vaGV1cjdyZDZsV0NjVzNoOG9jbHlDaE9lT3o5Z1dOV1llNkVheWFiallFTTlwRDYzZ3FvRW44cEhtZEY3VWpNS2tJbWs3dV9wTU5PZl8yQUlfUHpMcDhZSjRUVTdWUnJkcXVES2NINHNRSEV3QjdGbHN4d2NWOWM?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2022-10-18T07:00:00+00:00", "published_display": "18 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Growth strategy \u201cTOP I 2030\u201d | Management Policy | Investor Relations | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQb2pEYTVaS3prb0VvNzZtcE1fZXFTUmJvWTZfWEdIb0pQN2VNakRzM3V0LVhIR1dibHZoclBraWhqeVdNLWxLd3Fna3M2dmVadVNXUDRBNHpKYXBQRDE3YUx1bnJPY0JEN0c2THl6aF9aRlpQeGFXYlJVTnlPa2RlcHFn?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2021-02-04T09:35:08+00:00", "published_display": "04 Feb 2021 09:35", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sustainability Data 2025 | Data | Sustainability | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFBjRWlRMU8yNFFuWUNrZkY3bHk0QVVKbHY5SDFQLTd0Mlo2UGJJVnFFaVFaOW1WQlN6bjlpRy1hNUFEUUdleDVDejgxd0VUbjJDRUlLSG5VempIczkzV3BxbTlXWVI3cm1wbXFuWHFPYnlBWlRfck9pX1Bn?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2019-10-01T02:34:37+00:00", "published_display": "01 Oct 2019 02:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strategic Alliance with Roche | Our Strategy | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxObklpOTNSdV8tQmlSQTJKdWVhcUZQLWxxOUpHMzg4b3RyQVNFTnByVE5KOG9PajRuNXZRSk5Ba3ZfVHhzOGJ1Y091RWljSHZuYkdSdUIxUmV4WnB5cmQ4NnBiSkVLalZhdjlBckxqQnU5SkY1OGNveTVEeFhyNmd3TQ?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2018-10-01T01:21:56+00:00", "published_display": "01 Oct 2018 01:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investor Relations | CHUGAI PHARMACEUTICAL CO., LTD.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTFBYRXBqcTQ4RXJQZFU5ZkRDWVR1ZVRyMloxUWxIRGtPQlI3V2EzWFhjdUl1Q2lwVDhsa0JUQVRBeG92YUhLYzBmd0J3SXhqd3dqOXM4ZQ?oc=5", "source_name": "chugai-pharm.co.jp", "published_at": "2006-06-11T04:29:33+00:00", "published_display": "11 Jun 2006 04:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 82, "total_relevant": 18, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 17, "score": 51, "total": 18, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 9.15, "count": 16}, {"event": "earnings", "label": "Earnings", "weight": 0.9, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 7389.0, "latest_week": "2026-07-10", "one_week_move": -3.3, "four_week_move": 0.1, "twelve_week_move": -11.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.142409, "market_dynamics_buy_signal": false, "relative_strength": -27.546972, "fair_value_gap": 14.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 63.2746, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.3% over one week, +0.1% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "chugai-pharm.co.jp", "count": 7}, {"label": "MSN", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "Seeking Alpha", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Pharmaceutical Technology", "count": 1}, {"label": "citybiz", "count": 1}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 16}, {"label": "Earnings", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.3% over one week, +0.1% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Chugai Pharmaceutical Co Ltd (4519)"}], "updated_at": "2026-07-17T00:23:24.543668+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}